Jump to Main Contents

Home > Organization > Fundamental Innovative Oncology Core > Omics Core > Department of Clinical Proteomics

Department of Clinical Proteomics


We have originally developed a new analyzing system of proteome generated by liquid chromatography and mass spectrometry (LCMS), named 2DICAL (2-Dimensional Image Converted Analysis of LCMS). Using the system, we have archived important success in the field of medicine and biology. Now we are developing a new integrated system contributing clinical diagnosis and therapy based on the network information of proteome data. In addition, we have applied our in-house reverse-phase protein array (RPPA) platform to the discovery and development of biomarkers for companion diagnostics and precision medicine.